Clinical Trial

nTMS for Negative Symptom in Schizophrenia

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 5, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
This research aims to test the effectiveness of Navigated transcranial magnetic stimulation (nTMS) of left Supramarginal Gyrus for negative symptoms. In this double-blind, randomized controlled trial, patients will be assigned to active iTBS experimental group or sham iTBS group. Treatment will last for 10 days, and data will be collected at baseline, 1 day and 1 month after treatment.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2024-10-11; most recent amendment 2025-12-01.
Status change: Active, Not Recruiting → Recruiting 2024-12-03
Status change: Not Yet Recruiting → Active, Not Recruiting 2024-11-05
Trial Details
NCT Number NCT06642675
Lead Sponsor Central South University
Conditions Schizophrenia
Enrollment 40 participants
Start Date 2024-11-22
Primary Completion 2026-02 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2025-12-05